retatrutide mg + CAGRILINTIDE – Research Peptide Retatrutide (GLP-3) – Y&P Labs

Endocrinology 133: 57-62, 1993

By 2030, we expect the market size to exceed $100 billion in the U.S. It is estimated that by then, 1 in 10 Americans will be on a GLP-1 medication

Proc Natl Acad Sci USA 104:1506915074 Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study

The product targets people who want appetite suppression and weight management support but do not want or cannot access prescription GLP-1 medications

Your personal body chemistry matters, too

However, preliminary research suggests that the infusions can indeed help improve the health of your cells and boost energy